18
Participants
Start Date
July 26, 2019
Primary Completion Date
August 9, 2022
Study Completion Date
August 9, 2022
BI 754132
One single injection
Mid Atlantic Retina, Philadelphia
Western Carolina Retinal Associate PA, Asheville
Southeast Retina Center, PC, Augusta
Retina Specialty Institute, Pensacola
Center for Retina and Macular Disease, Winter Haven
Retina Foundation of the Southwest, Dallas
Retina Consultants of Texas, Bellaire
Retina-Vitreous Associates Medical Group, Beverly Hills
Bristol Eye Hospital, Bristol
Royal Liverpool University Hospital, Liverpool
Moorfields Eye Hospital, London
Royal Victoria Infirmary, Newcastle upon Tyne
Southampton General Hospital, Southampton
Lead Sponsor
Boehringer Ingelheim
INDUSTRY